Research Article
BibTex RIS Cite

In vitro therapy investigation for breast cancer by B13-chloroquine application

Year 2024, Volume: 17 Issue: 2, 105 - 111, 15.08.2024
https://doi.org/10.46309/biodicon.2024.1353221

Abstract

Cancer disease still remains to be strong treat for public health. New treatment approaches and agents with low side effects are needed for the treatment of breast cancer. Based on these, herein was aimed to investigate the cytotoxicity of a combination comprising a ceramidase inhibitor (B13) and an autophagy inhibitor (chloroquine) on human breast cancer cell line. The antiproliferative activity was tested by Sulforhodamine B and ATP viability assays. For ultrastructural and morphological changes and apoptotic signs of MCF-7 cells were used TEM and confocal microscopy techniques. Results showed the high cytotoxic and antiproliferative activities of the combination along with the ultrastructural and morphological changes indicating apoptosis. B13+Chloroquine combinations found to be effective on inducing cell death on MCF-7 cells and antiproliferative and cytotoxic effects on cells. Consequently, the new combination is suggested as good candidate for further investigations to be an anti-cancer agent.

Supporting Institution

Anadolu University

Project Number

This study was supported by Anadolu University Scientific Research Project Unit with project number: 1901S002.

Thanks

This study was supported by Anadolu University Scientific Research Project Unit with project number: 1901S002.

References

  • References
  • [1] Mughal, T. A., Aslam, F., Yousaf, Z., Numrah, N., & Ping, C. L. (2020). In vitro cytotoxic activity of Zaleya pentandra L. extracts against the breast cancer adenocarcinoma cell line MCF-7. Journal of Pakistan Medical Association, 70, 35-41.
  • [2] Shen, S., Huang, L. S, Xiao, X. L., Zhu, X. F., Xiong, D. D., Cao, X. M., Wei, K. L., Chen, G., & Feng, Z. B. (2017). miR-204 regulates the biological behavior of breast cancer MCF-7 cells by directly targeting FOXA1. Oncology Reports, 38, 368-376.
  • [3] Nedaei, S. H., Akbari, H., & Yaghoubi, H. (2019). Cytotoxicity effects of green synthesized silver nanoparticles by using the extract of Tuber spp. on breast cancer (MCF-7) cells. Journal of Babol University Medical Sciences, 21, 242-48.
  • [4] Jardim, D. L., De Melo Gagliato, D., Nikanjam, M., Barkauskas, D. A., & Kurzrock, R. (2020). Efficacy and safety of anticancer drug combinations: a meta-analysis of randomized trials with a focus on immunotherapeutics and gene-targeted compounds. Oncoimmunology, 9, 1710052.
  • [5] Verbaanderd, C., Maes, H., Schaaf, M.B., Sukhatme, V. P., Pantziarka, P., Sukhatme, V., Agostinis, P., & Bouche, G. (2017). Repurposing drugs in oncology (redo)-chloroquine and hydroxychloroquine as anti-cancer agents. E. Cancer Medical Science. 23 (11) 781.
  • [6] Manic, G., Obrist, F., Kroemer, G., Vitale, I., & Galluzzi, L., (2014). Chloroquine and hydroxychloroquine for cancer therapy. Molecular and Cellular Oncology, 15, e29911.
  • [7] Al-Bari, M.A. (2015). Chloroquine analogues in drug discovery: new directions of uses, mechanisms of actions and toxic manifestations from malaria to multifarious diseases. Journal of Antimicrobial Chemotherapy, 70(6), 1608-1621.
  • [8] Selzner, M., Bielawska, A., Morse, M.A., Rüdiger, H. A., Sindram, D., Hannun, Y. A., & Clavien P. A., (2001). Induction of apoptotic cell death and prevention of tumor growth by ceramide analogues metastatic human colon cancer. Cancer Research, 61, 1233–1240.
  • [9] Raisova, M., Goltz, G., Bektas, M., Bielawska, A., Riebeling, C., Hossini, A. M., Eberle, J., Hannun, Y. A. Orfanos, C. E., & Geilen, C. C., (2002). Bcl-2 overexpression prevents apoptosis induced by ceramidase inhibitors in malignant melanoma and HaCaT keratinocytes. FEBS Letters, 516, 47–52.
  • [10] Samsel, L., Zaidel, G., Drumgoole, H. M., Jelovac, D., Drachenberg, C., Rhee, J., Brodie, A., Bielawska, A., & Smyth, M., (2004). The ceramide analog, B13, induces apoptosis in prostate cancer cell lines and inhibits tumor growth in prostate cancer xenografts. Prostate, 58, 382–393.
  • [11] Vejselova Sezer, C. (2021). Cytotoxic impacts of escin via inducing apoptosis and morphological changes on human prostate cancer cells. Biyolojik Çeşitlilik ve Koruma, 14 (1) , 82-87.
  • [12] Al-Attar, T. & Madihally, S. V. (2020). Recent advances in the combination delivery of drug for leukemia and other cancers. Expert Opinion in Drug Delivery, 17, 213-223.
  • [13] Fares, J., Kanojia, D., Rashidi, A., Ulasov, I., & Lesniak, M. S., (2020). Landscape of combination therapy trials in breast cancer brain metastasis. International Journal of Cancer, 147, 1939–1952.
  • [14] Schonewolf, C. A., Mehta, M., Schiff, D., Wu, H., Haffty, B. G., Karantza, V., & Jabbour S. K., (2014). Autophagy inhibition by chloroquine sensitizes HT-29 colorectal cancer cells to concurrent chemoradiation. World Journal of Gastrointestinal Oncology, 15, 74-82.
  • [15] Danial, N. N. & Korsmeyer, S. J. (2004). Cell death: critical control points. Cell, 116, 205-219.
  • [16] Kang, M. H. & Reynolds, C. P. (2009). Bcl-2 inhibitors: targeting mitochondrial apoptotic pathways in cancer therapy. Clinical Cancer Research,15(4), 1126-32.
  • [17] Liu, F., Shang, Y., & Chen, S. (2014). Chloroquine potentiates the anti-cancer effect of lidamycin on non-small cell lung cancer cells in vitro. Acta Pharmacologica Sinica, 35, 645–652.
  • [18] Solomon, V. R. & Lee, H. (2009). Chloroquine and its analogs: a new promise of an old drug for effective and safe cancer therapies. European Journal of Pharmacology, 625, 220–33.
  • [19] Fan, C., Wang, W., Zhao, B., Zhang, S., & Miao, J. (2006). Chloroquine inhibits cell growth and induces cell death in A549 lung cancer cells. Journal of Bioorganic and Medicinal Chemistry, 14(9), 3218-3222.
  • [20] Jiang, P. D., Zhao, Y. L., Deng, X. Q., Mao, Y. Q., Shi, W., Tang, Q. Q., Li, Z. G., Zheng, Y. Z., Yang, S. Y., & Wei, Y. W., (2010). Antitumor and antimetastatic activities of chloroquine diphosphate in a murine model of breast cancer. Biomedical Pharmacotherapy, 64, 609–614.

Meme kanserinde B13-klorokin uygulamasıyla in vitro tedavi araştırması

Year 2024, Volume: 17 Issue: 2, 105 - 111, 15.08.2024
https://doi.org/10.46309/biodicon.2024.1353221

Abstract

Kanser hastalığı hala halk sağlığı için ciddi bir tehdit olmaya devam edmektedir. Meme kanseri tedavisi için yeni tedavi yaklaşımlarına ve yan etkisi düşük ajanlara ihtiyaç duyulmaktadır. Bunlara dayanarak, burada bir seramidaz inhibitörü (B13) ve bir otofaji inhibitörü (klorokin) içeren bir kombinasyonun insan meme kanseri hücre hattı üzerindeki sitotoksisitesinin araştırılması amaçlanmıştır. Antiproliferatif aktivite, Sulforhodamine B ve ATP canlılık deneyleri ile test edilmiştir. MCF-7 hücrelerinin ince yapısal ve morfolojik değişiklikleri ve apoptotik belirtileri için TEM ve konfokal mikroskopi teknikleri kullanılmıştır. Sonuçlar, kombinasyonun yüksek sitotoksik ve antiproliferatif aktivitelerinin yanı sıra apoptozu gösteren ince yapısal ve morfolojik değişikliklere neden olduğunu göstermiştir. B13+Klorokin kombinasyonunun MCF-7 hücrelerinde ölümü tetiklediği, antiproliferatif ve sitotoksik etkilere neden olduğu saptanmıştır. Sonuç olarak, yeni kombinasyonun antikanser bir ajan olarak ileri araştırmalar için iyi bir aday olduğu ortaya konulmuştur.

Project Number

This study was supported by Anadolu University Scientific Research Project Unit with project number: 1901S002.

References

  • References
  • [1] Mughal, T. A., Aslam, F., Yousaf, Z., Numrah, N., & Ping, C. L. (2020). In vitro cytotoxic activity of Zaleya pentandra L. extracts against the breast cancer adenocarcinoma cell line MCF-7. Journal of Pakistan Medical Association, 70, 35-41.
  • [2] Shen, S., Huang, L. S, Xiao, X. L., Zhu, X. F., Xiong, D. D., Cao, X. M., Wei, K. L., Chen, G., & Feng, Z. B. (2017). miR-204 regulates the biological behavior of breast cancer MCF-7 cells by directly targeting FOXA1. Oncology Reports, 38, 368-376.
  • [3] Nedaei, S. H., Akbari, H., & Yaghoubi, H. (2019). Cytotoxicity effects of green synthesized silver nanoparticles by using the extract of Tuber spp. on breast cancer (MCF-7) cells. Journal of Babol University Medical Sciences, 21, 242-48.
  • [4] Jardim, D. L., De Melo Gagliato, D., Nikanjam, M., Barkauskas, D. A., & Kurzrock, R. (2020). Efficacy and safety of anticancer drug combinations: a meta-analysis of randomized trials with a focus on immunotherapeutics and gene-targeted compounds. Oncoimmunology, 9, 1710052.
  • [5] Verbaanderd, C., Maes, H., Schaaf, M.B., Sukhatme, V. P., Pantziarka, P., Sukhatme, V., Agostinis, P., & Bouche, G. (2017). Repurposing drugs in oncology (redo)-chloroquine and hydroxychloroquine as anti-cancer agents. E. Cancer Medical Science. 23 (11) 781.
  • [6] Manic, G., Obrist, F., Kroemer, G., Vitale, I., & Galluzzi, L., (2014). Chloroquine and hydroxychloroquine for cancer therapy. Molecular and Cellular Oncology, 15, e29911.
  • [7] Al-Bari, M.A. (2015). Chloroquine analogues in drug discovery: new directions of uses, mechanisms of actions and toxic manifestations from malaria to multifarious diseases. Journal of Antimicrobial Chemotherapy, 70(6), 1608-1621.
  • [8] Selzner, M., Bielawska, A., Morse, M.A., Rüdiger, H. A., Sindram, D., Hannun, Y. A., & Clavien P. A., (2001). Induction of apoptotic cell death and prevention of tumor growth by ceramide analogues metastatic human colon cancer. Cancer Research, 61, 1233–1240.
  • [9] Raisova, M., Goltz, G., Bektas, M., Bielawska, A., Riebeling, C., Hossini, A. M., Eberle, J., Hannun, Y. A. Orfanos, C. E., & Geilen, C. C., (2002). Bcl-2 overexpression prevents apoptosis induced by ceramidase inhibitors in malignant melanoma and HaCaT keratinocytes. FEBS Letters, 516, 47–52.
  • [10] Samsel, L., Zaidel, G., Drumgoole, H. M., Jelovac, D., Drachenberg, C., Rhee, J., Brodie, A., Bielawska, A., & Smyth, M., (2004). The ceramide analog, B13, induces apoptosis in prostate cancer cell lines and inhibits tumor growth in prostate cancer xenografts. Prostate, 58, 382–393.
  • [11] Vejselova Sezer, C. (2021). Cytotoxic impacts of escin via inducing apoptosis and morphological changes on human prostate cancer cells. Biyolojik Çeşitlilik ve Koruma, 14 (1) , 82-87.
  • [12] Al-Attar, T. & Madihally, S. V. (2020). Recent advances in the combination delivery of drug for leukemia and other cancers. Expert Opinion in Drug Delivery, 17, 213-223.
  • [13] Fares, J., Kanojia, D., Rashidi, A., Ulasov, I., & Lesniak, M. S., (2020). Landscape of combination therapy trials in breast cancer brain metastasis. International Journal of Cancer, 147, 1939–1952.
  • [14] Schonewolf, C. A., Mehta, M., Schiff, D., Wu, H., Haffty, B. G., Karantza, V., & Jabbour S. K., (2014). Autophagy inhibition by chloroquine sensitizes HT-29 colorectal cancer cells to concurrent chemoradiation. World Journal of Gastrointestinal Oncology, 15, 74-82.
  • [15] Danial, N. N. & Korsmeyer, S. J. (2004). Cell death: critical control points. Cell, 116, 205-219.
  • [16] Kang, M. H. & Reynolds, C. P. (2009). Bcl-2 inhibitors: targeting mitochondrial apoptotic pathways in cancer therapy. Clinical Cancer Research,15(4), 1126-32.
  • [17] Liu, F., Shang, Y., & Chen, S. (2014). Chloroquine potentiates the anti-cancer effect of lidamycin on non-small cell lung cancer cells in vitro. Acta Pharmacologica Sinica, 35, 645–652.
  • [18] Solomon, V. R. & Lee, H. (2009). Chloroquine and its analogs: a new promise of an old drug for effective and safe cancer therapies. European Journal of Pharmacology, 625, 220–33.
  • [19] Fan, C., Wang, W., Zhao, B., Zhang, S., & Miao, J. (2006). Chloroquine inhibits cell growth and induces cell death in A549 lung cancer cells. Journal of Bioorganic and Medicinal Chemistry, 14(9), 3218-3222.
  • [20] Jiang, P. D., Zhao, Y. L., Deng, X. Q., Mao, Y. Q., Shi, W., Tang, Q. Q., Li, Z. G., Zheng, Y. Z., Yang, S. Y., & Wei, Y. W., (2010). Antitumor and antimetastatic activities of chloroquine diphosphate in a murine model of breast cancer. Biomedical Pharmacotherapy, 64, 609–614.
There are 21 citations in total.

Details

Primary Language English
Subjects Cell Development, Proliferation and Death
Journal Section Research Articles
Authors

Emre Çömlekçi 0000-0002-7597-0381

Canan Vejselova Sezer 0000-0002-3792-5993

Hatice Mehtap Kutlu 0000-0002-8816-1487

Ömer Koray Yaylacı 0000-0002-1846-9646

Gokhan Kus 0000-0002-2424-2720

Project Number This study was supported by Anadolu University Scientific Research Project Unit with project number: 1901S002.
Early Pub Date May 11, 2024
Publication Date August 15, 2024
Submission Date August 31, 2023
Acceptance Date March 6, 2024
Published in Issue Year 2024 Volume: 17 Issue: 2

Cite

APA Çömlekçi, E., Vejselova Sezer, C., Kutlu, H. M., Yaylacı, Ö. K., et al. (2024). In vitro therapy investigation for breast cancer by B13-chloroquine application. Biological Diversity and Conservation, 17(2), 105-111. https://doi.org/10.46309/biodicon.2024.1353221

❖  Abstracted-Indexed in
Web of Science {Zoological Records Indexed] Clavariate Analytic, Medical Reads (RRS), CrossRef;10.46309/biodicon.

❖ Libraries
Aberystwyth University; All libraries; Bath University; Birmingham University; Cardiff University; City University London; CONSER (Not UK Holdings); Edinburgh University; Essex University; Exeter University; Eskişehir Technical University Library; EZB Electronic Journals Library; Feng Chia University Library; GAZİ Gazi University Library; Glasgow University; HEC-National Digital Library; Hull University; Imperial College London; Kaohsinug Medical University Library; ANKOS; Anadolu University Library; Lancaster University; Libros PDF; Liverpool University; London Metropolitan University; London School of Economics and Political Science; Manchester University; National Cheng Kung University Library; National ILAN University Library; Nottingham University; Open University; Oxford University; Queen Mary,University of London;Robert Gordon University; Royal Botanic Gardens, Kew; Sheffield Hallam University; Sheffield University; Shih Hsin University Library; Smithsonian Institution Libraries; Southampton University; Stirling University; Strathclyde University; Sussex University; The National Agricultural Library (NAL); The Ohio Library and Information NetWork; Trinity College Dublin; University of Washington Libraries; Vaughan Memorial Library; York University..

❖ The article processing is free.

❖ Web of Science-Clarivate Analytics, Zoological Record
❖ This journal is a CrossRef;10.46309/biodicon. member

❖ Please visit ” http:// www.biodicon.com“ ; "https://dergipark.org.tr/en/pub/biodicon"   for instructions about articles and all of the details about journal


❖  Correspondance Adres: Prof. Ersin YÜCEL, Sazova Mahallesi, Ziraat Caddesi, No.277 F Blok, 26005 Tepebaşı-Eskişehir/Türkiye
E-posta / E-mail: biodicon@gmail.com;
Web Address: http://www.biodicon.com;   https://dergipark.org.tr/en/pub/biodicon
❖ Biological Diversity and Conservation/ Biyolojik Çeşitlilik ve Koruma
❖ ISSN 1308-5301 Print; ISSN 1308-8084 Online
❖ Start Date Published 2008
© Copyright by Biological Diversity and Conservation/Biyolojik Çeşitlilik ve Koruma-Available online at www.biodicon.com/All rights reserved
Publisher : ERSİN YÜCEL (https://www.ersinyucel.com.tr/)
❖ This journal is published three numbers in a year. Printed in Eskişehir/Türkiye.
❖ All sorts of responsibilities of the articles published in this journal are belonging to the authors
Editör / Editor-In-Chief : Prof.Dr. Ersin YÜCEL, https://orcid.org/0000-0001-8274-7578